Last $60.13 USD
Change Today -0.87 / -1.43%
Volume 243.7K
DXCM On Other Exchanges
DXCM is not on other exchanges.
As of 1:58 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

dexcom inc (DXCM) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/27/15 - $63.56
52 Week Low
05/2/14 - $28.09
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for DEXCOM INC (DXCM)

dexcom inc (DXCM) Related Businessweek News

No Related Businessweek News Found

dexcom inc (DXCM) Details

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. It offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. The company’s ambulatory product line includes SEVEN PLUS, DexCom G4 system, and DexCom G4 PLATINUM system for adults with diabetes to detect trends and track glucose patterns, to aid in the detection of hypoglycemia and hyperglycemia, and to facilitate acute and long-term therapy adjustments, as well as DexCom SHARE, a remote monitoring system, which provides secondary notification and does not replace real time continuous glucose monitoring or standard home blood glucose monitoring. Its in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. The company also offers SweetSpot, a software platform that enables patients to aggregate and analyze data from diabetes devices and to share it with their healthcare providers. It markets its products directly to endocrinologists, physicians, and diabetes educators primarily in the United States. The company was founded in 1999 and is headquartered in San Diego, California.

646 Employees
Last Reported Date: 02/20/14
Founded in 1999

dexcom inc (DXCM) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $325.0K
Executive Chairman
Total Annual Compensation: $420.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $237.0K
Chief Technical Officer
Total Annual Compensation: $284.9K
Executive Vice President of Strategy & Corpor...
Total Annual Compensation: $284.9K
Compensation as of Fiscal Year 2013.

dexcom inc (DXCM) Key Developments

DexCom, Inc. - Special Call

To consider and receive U.S. Food and Drug Administration approval for its Dexcom G4 PLATINUM continuous Glucose Monitoring System with share

DexCom, Inc. Announces Revenue Results for the Fourth Quarter and Full Year of 2014; Provides Revenue Guidance for Fiscal 2015

DexCom, Inc. announced revenue results for the fourth quarter and full year of 2014. Revenue for the fourth quarter this year were $84 million. That's up 24% sequentially from third quarter and up 64% from the fourth quarter of 2013. Annually, the company reported $257 million in revenue for the year with an annual growth percentage also of 64%. With respect to 2015, it is going to give revenue guidance for fiscal 2015 and that growth is 35% to 40% for the year, a range of $340 million to $360 million.

DexCom, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 03:30 PM

DexCom, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 03:30 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Kevin R. Sayer, Chief Executive Officer, President and Director.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DXCM:US $60.14 USD -0.86

DXCM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Insulet Corp $29.89 USD -0.12
Merge Healthcare Inc $3.83 USD -0.15
NeuStar Inc $26.47 USD -0.175
Radview Software Ltd $0.0017 USD -0.0003
Tandem Diabetes Care Inc $12.34 USD -0.14
View Industry Companies

Industry Analysis


Industry Average

Valuation DXCM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 20.4x
Price/Book 40.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 20.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DEXCOM INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at